Unique localization of circulating tumor cells in patients with hepatic metastases.

PURPOSE There are few data on the impact of immediate and differing surgical interventions on circulating tumor cells (CTCs), nor their compartmentalization or localization in different anatomic vascular sites. PATIENTS AND METHODS CTCs from consecutive patients with colorectal liver metastases were quantified before and immediately after open surgery, laparoscopic resection, open radiofrequency ablation (RFA), or percutaneous RFA. For individuals undergoing open surgery, either hepatic resections or open RFA, CTCs were examined in both systemic and portal circulation by measuring CTCs in samples derived from the peripheral vein, an artery, the hepatic portal vein, and the hepatic vein. RESULTS A total of 29 consecutive patients with colorectal liver metastases with a median age of 55 years (range, 30 to 88 years) were included. CTCs were localized to the hepatic portosystemic macrocirculation with significantly greater numbers than in the systemic vasculature. Surgical procedures led to a statistically significant fall in CTCs at multiple sites measured. Conversely, RFA, either open or percutaneous, was associated with a significant increase in CTCs. CONCLUSION Surgical resection of metastases, but not RFA, immediately decreases CTC levels. In patients with colorectal liver metastases, CTCs appear localized to the hepatic (and pulmonary) macrocirculations. This may explain why metastases in sites other than the liver and lungs are infrequently observed in cancer.

[1]  S. Choi,et al.  Clinical Outcomes of Hepatic Resection and Radiofrequency Ablation in Patients With Solitary Colorectal Liver Metastasis , 2008, Journal of clinical gastroenterology.

[2]  K. McMasters,et al.  Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent? , 2009, Journal of Gastrointestinal Surgery.

[3]  W. Sauerbrei,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.

[4]  E. Yagüe,et al.  Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. , 2009, Pharmacogenomics.

[5]  Byung Soh Min,et al.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. , 2009, American journal of surgery.

[6]  R. Coombes,et al.  Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  U. Neumann,et al.  Open Surgical is Superior to Percutaneous Access for Radiofrequency Ablation of Hepatic Metastases , 2009, World Journal of Surgery.

[8]  Dongil Choi,et al.  Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function , 2005, Journal of clinical gastroenterology.

[9]  M. Koch,et al.  Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination – prospective randomized multicenter trial , 2008, BMC surgery.

[10]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[11]  M. Lorenz,et al.  Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model , 1999, The British journal of surgery.

[12]  M. Dowsett,et al.  Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques , 2005, British Journal of Cancer.

[13]  A. Zaniboni,et al.  Molecular signature detection of circulating tumor cells using a panel of selected genes. , 2008, Cancer letters.

[14]  J. Stebbing,et al.  Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear. , 2008, Future oncology.

[15]  M. Beckmann,et al.  Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: The German SUCCESS-Trial , 2008 .

[16]  J. Stebbing,et al.  New biomarkers in breast cancer: microRNAs and leptins--where are we now? , 2007, Biomarkers in medicine.

[17]  R C Coombes,et al.  Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment , 2008, British Journal of Cancer.

[18]  Katharina Pachmann,et al.  Standardized quantification of circulating peripheral tumor cells from lung and breast cancer , 2005, Clinical chemistry and laboratory medicine.

[19]  Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer , 2006, British Journal of Cancer.

[20]  N. Gusani,et al.  Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy , 2009, Annals of Surgical Oncology.

[21]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Fakih Carcinoembryonic antigen monitoring in metastatic colorectal cancer: words of caution. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[24]  M. Molinari,et al.  Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. , 2009, American journal of surgery.

[25]  I. Vlachonikolis,et al.  Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  T. Kroll,et al.  Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Choti,et al.  Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. , 2008, Archives of surgery.

[28]  D. Jäger,et al.  [Systemic therapy for colorectal cancer]. , 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[29]  M. Lorenz,et al.  Impact of laparoscopic surgery on experimental hepatic metastases , 2001, The British journal of surgery.

[30]  P. Farmer,et al.  Synthesis and analysis of DNA adducts of arylamines. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[31]  Georgios Giamas,et al.  Clinical significance of circulating tumor cells. , 2007, Biomarkers in medicine.